Meanwhile, the company’s stock price has increased by more than 8% since the SEC filing, and it finished the most recent trading session with a gain of 6.45%. Additionally, in its latest earnings report, the company managed to beat Wall Street’s expectations by posting $195.1 million of revenue, a beat by $18.86 million. Similarly, the company beat earnings per share (EPS) by $0.03, to a total EPS of $0.30.
AMEH chart analysis
Presently, despite closing in the green during the last session, the shares did not manage to close above the 50-day Simple Moving Average (SMA). Further, a significant trading volume increase has been noted in June compared to May; however, the shares are down over 44% year-to-date (YTD).
Pioneer of a business model
In essence, Apollo is a platform that connects all involved stakeholders (payor, physician, and patient), and provides data-driven solutions enabling the physicians to deliver the best care possible. Moreover, the strength of the business model is reflected in the growth rate, with annualized revenue growing over 22% and EPS growth of over 20% in the past four years. This trend should continue in the near future as the firm expects the number of its members to start steadily growing. Equally important, the growing risks surrounding the rise of inflation and policies undertaken by the Federal Reserve (Fed) could negatively impact the availability of capital for growth. The current valuation of the company by price to earnings (P/E) ratio is 62.67, which in turn is higher than the industry average. Finally, the possibility of an economic slowdown negatively affecting growth stocks is a trend observed so far throughout 2022. According to experts, a chance of a further market pull-back seems quite possible, which may result in an additional price drop of AMEH shares. Buy stocks now with Interactive Broker – the most advanced investment platform Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.
